Skip to content

PKU Healthcare controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2016

    Regulatory action over shareholder arrangements

    The supplied reference states that the China Securities Regulatory Commission fined PKU Healthcare Group, Beijing Zenith Holdings, and PKU Resources Group Holdings after the disclosed share-transfer and proxy-holding arrangements. The episode concerned ownership, payment, and control arrangements rather than a pharmaceutical product safety issue.